---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-016502"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2023-05-12T23:59:59+00:00"
generated_at: "2026-06-15T02:49:06.092676+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Biofrontera CEO Monaco resigns; Luebbert takes over; Q1 revenue $8.7M, net loss $7.5M

## Summary
- CEO Erica Monaco resigning; Executive Chairman Hermann Luebbert to assume CEO role; effective near term.
- Q1 2023 revenue $8.7M, down 11% YoY due to prior-year buy-in; net loss $7.5M vs net income $5.6M.
- Q1 2023 net loss per share $(0.28) vs prior-year EPS $0.32; adjusted EBITDA -$4.0M.
- Cash and cash equivalents $13.5M as of March 31, 2023, down from $17.2M Dec 31, 2022.
- Affirms full-year 2023 revenue growth at least 25% vs 2022; expects cash flow positive within two years.

## SEC filing metadata
- accession: 0001493152-23-016502
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2023-05-12T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000149315223016502/0001493152-23-016502-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000149315223016502/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-016502
- JSON: https://secwatch.observer/filing/0001493152-23-016502.json
- Plain text: https://secwatch.observer/filing/0001493152-23-016502.txt

## Key facts
- Earnings Releases
  Biofrontera Inc. reported first quarter ended March 31, 2023 results: revenue $8.7 million, EPS $(0.28) per share. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2023
  - Revenue: $8.7 million
  - EPS: $(0.28) per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: Total revenues for the first quarter of 2023 were $8.7 million compared with $9.8 million for the first quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858685/000149315223016502/0001493152-23-016502-index.htm
- Executive change
  Erica Monaco departed as Chief Executive Officer at Biofrontera Inc..
  - Action: resign
  - Role: Chief Executive Officer
  source text: Erica Monaco, Chief Executive Officer of the Company notified the Company’s Board of Directors that she intends to resign from the Company to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858685/000149315223016502/0001493152-23-016502-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.